Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BMs Farmaci AB
AB
Dissolved
Org 5592022122
Retail sale of pharmaceutical products
· NACE 4773
Est. 2019
0 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
BMs Farmaci AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
0M
2022
0M
2023
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
0M
2023
Income statement
SEK thousands
Item
2020
2021
2022
2023
Revenue
1 227
1 169
255
103
Staff expenses
—
—
—
—
EBITDA
740
389
99
29
Depreciation & amort.
−0
−0
−0
−0
EBIT
740
389
99
29
Net financials
—
—
—
—
Profit before tax
590
289
217
53
Tax
−129
−66
−52
−18
Net profit
461
223
165
35
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
Total assets
876
1 023
732
520
Equity
511
557
552
407
Long-term debt
0
0
0
0
Short-term debt
215
216
48
6
Total debt
215
216
48
6
Financial ratios
5-year trend
EBITDA margin
28.2%
This company
15.8%
Market median
+78% vs market
2020
2023
Equity ratio
78.3%
This company
38.2%
Market median
+105% vs market
2020
2023
Return on equity
8.6%
This company
18.4%
Market median
-53% vs market
2020
2023
Net profit margin
34.0%
This company
8.1%
Market median
+320% vs market
2020
2023
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
2020
2023
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
2020
2023
Annual reports & filings
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-04-01 – 2020-03-31
View
PDF
More on BMs Farmaci AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot